DAVID ROSS, MD
Medical Oncology Physician · ROCKLEDGE, FL
Individual Active NPI 1912959594
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 691 | 172,014 | $14,998,656 | $4,334,954 | $3,451,242 |
| 2023 | 706 | 204,374 | $13,976,232 | $3,677,411 | $2,924,947 |
| 2022 | 629 | 208,363 | $12,812,794 | $3,286,605 | $2,625,845 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 23,400 | $56 | $45 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 16,055 | $3 | $2 |
| J9267 | Injection, paclitaxel, 1 mg | 7,730 | $0 | $0 |
| J0897 | Injection, denosumab, 1 mg | 7,560 | $25 | $20 |
| J1453 | Injection, fosaprepitant, 1 mg | 7,500 | $0 | $0 |
| J9119 | Injection, cemiplimab-rwlc, 1 mg | 7,350 | $27 | $22 |
| J1437 | Injection, ferric derisomaltose, 10 mg | 4,200 | $20 | $16 |
| J0185 | Injection, aprepitant, 1 mg | 3,510 | $2 | $1 |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 2,610 | $46 | $37 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,846 | $0 | $0 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1,200 | $0 | $0 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 1,020 | $1 | $1 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | ME90807 | FL |
| Medical Oncology Physician | 207RX0202X | 2008000497 | MO |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Florida
- NPI 1962507863
- NPI 1124085014
- NPI 1215101902
- NPI 1861729170
- NPI 1811967243
- NPI 1699778894
- NPI 1184937518
- NPI 1073742359
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.